Skip to content
Catalyst

PapersPMID:35368930

Effect of Resveratrol Combined with Donepezil Hydrochloride on Inflammatory Factor Level and Cognitive Function Level of Patients with Alzheimer's Disease.

Journal of healthcare engineering2022The record ↗

  1. Finding, moderate evidenceraisesMini-Mental State Examination total score

What moved

1 findingHow to read these marks →
  • “Compared with CG after treatment, EG obtained obviously higher MMSE score (P < 0.001) and significantly lower ADAS-cog score (P < 0.001) (see Figure 1).”
    Study
    RCT
    Participants
    90
    Duration
    2 months
    Dose studied
    1-2 RES tablets (1.0 g each) daily as a dietary supplement, added to donepezil hydrochloride
    Population
    patients with Alzheimer's disease, all also receiving donepezil hydrochloride as background therapy in both arms (EG: donepezil + resveratrol; CG: donepezil alone), 2-month treatment

Study record

Design
randomised controlled trial
Species
human
Population
patients with Alzheimer's disease
Participants
90
Comparator
an active treatment / placebo
Duration
61 days
Endpoints measured
7